Pfizer (PFE:US) recently announced in "The Year Ahead, Biopharma Breakthroughs" that Gene Therapy is one of its hottest areas and that it is very active in three programs - DMD and two in haemophilia studies. PFE's market cap is ~ A$300 billion and they see DMD as one of their best areas for growth.
ANP is in the right place with room to grow - Pfizer is 10,000 times bigger.
Pfizer (PFE:US) recently announced in "The Year Ahead, Biopharma...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $99.16M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.5¢ | $160.3K | 1.467M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 577880 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 114554 | 3 |
View Market Depth
| Last trade - 11.46am 30/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |